Nader N Nasief Abdel Sayed

Title: Nader N. Nasief Abdel Sayed: Innovator in Pharmaceuticals

Introduction: Nader N. Nasief Abdel Sayed is an accomplished inventor based in Amherst, NY, recognized for his contributions to the pharmaceutical field. With a focus on developing compounds that address multi-drug resistance in cancers, he has made significant strides in medical research and innovation.

Latest Patents: Nader is the holder of a patent for "Acetamido-phenyltetrazole derivatives and methods of using the same," which discusses compounds useful in treating disorders related to P-glycoprotein and cytochrome P450 modulation. This patent outlines the preparation, pharmaceutical compositions, and applications of these compounds in combating cancers that have developed resistance to multiple drugs.

Career Highlights: Nader is currently employed at Athenex, Inc., a biopharmaceutical company dedicated to the research and development of innovative cancer therapies. His role at Athenex allows him to apply his expertise in the development of new therapeutic options that can better manage complex conditions.

Collaborations: Throughout his career, Nader has collaborated with talented professionals, including Sameer Urgaonkar and Ahmed M. Said. Their combined efforts have fostered innovation and enhanced research output within their respective fields.

Conclusion: Nader N. Nasief Abdel Sayed exemplifies the spirit of innovation in the pharmaceutical industry. His groundbreaking work on drug resistance not only contributes to the scientific community but also holds the potential to improve patient outcomes in cancer treatment.